Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vivan Therapeutics logo — Personalised cancer therapeutics platform pioneered at Mount...

Vivan Therapeutics

Personalised cancer therapeutics platform pioneered at Mount Sinai Medical Center.

Founded 2018 United Kingdom London, United Kingdom 18 employees Grant Total: $3.40M Big Data, Biotechnology +2

General Information

Company Name Vivan Therapeutics
Founded Year 2018
Location United Kingdom London, United Kingdom +1
Employees 18
Industries Big Data, Biotechnology, Health Care +1
Funding Stage Grant
Social

Get notified when Vivan Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vivan Therapeutics

Vivan Therapeutics is a biotechnology startup that has pioneered a personalized cancer therapeutics platform at Mount Sinai Medical Center. Founded in 2018, the company operates in the Big Data, Biotechnology, Health Care, Health and Wellness industries with its headquarters in the United Kingdom. Their most recent funding came in the form of a grant investment on December 19, 2022, with the European Innovation Council being the investors. This young company is steadily making a mark in the intersection of healthcare and technology with its innovative approach to cancer treatment.

Taxonomy: Blockchain technology, Digital Product Passport, Eco-friendly products, Viridis tokens, Revenue model, Tokenomics market, Public sale, Subscription model

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
19 Dec 2022
Seed Round •••••• 1 •••• •••• 01 Sep 2021
Series A •••••• 1
Investor
16 Jun 2021
Pre Seed Round •••••• 1
Investor
01 Mar 2019

Vivan Therapeutics Alternatives & Competitors

Vivan Therapeutics vs
Model Maker Group
Model Maker Group Italy

Fine scale model yachts

19 employees
Design, Manufacturing
Vivan Therapeutics vs
Verta
Verta United States

AI and ML Model Management and Operations for Enterprise Data Science Teams

13 employees
Vivan Therapeutics vs
QZY MODELS OFFICIAL
QZY MODELS OFFICIAL China

Creative Design and Architectural Model Making

6 employees
Design

FAQ About Vivan Therapeutics

Personalised cancer therapeutics platform pioneered at Mount Sinai Medical Center.
Vivan Therapeutics was founded in 2018.
Vivan Therapeutics is headquartered in London, United Kingdom.
Vivan Therapeutics operates in the following industries: Big Data, Biotechnology, Health Care, Health and Wellness.
Vivan Therapeutics has approximately 18 employees.
Vivan Therapeutics has completed 4 funding rounds, raising a total of $3.40M. The latest funding stage is Grant.
Top alternatives and competitors to Vivan Therapeutics include Model Maker Group, Verta, QZY MODELS OFFICIAL, Evidently AI , Airliners Distributing, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vivan Therapeutics and Model Maker Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vivan Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes